Skip Navigation

This Article
Right arrow Abstract Freely available
Right arrow Print PDF (218K) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (55)
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Saijo, M
Right arrow Articles by Tanaka, K
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Saijo, M
Right arrow Articles by Tanaka, K
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1996 Oxford University Press 4719-4724

Footnote

Sequential binding of DNA repair proteins RPA and ERCC1 to XPA in vitro

Sequential binding of DNA repair proteins RPA and ERCC1 to XPA in vitro Masafumi Saijo , Isao Kuraoka , Chikahide Masutani 1 , Fumio Hanaoka 1 and Kiyoji Tanaka*

Division of Cellular Genetics and 1 Division of Cellular Biology, Institute for Molecular and Cellular Biology, Osaka University, 1-3 Yamadaoka, Suita, Osaka 565, Japan

Received August 15, 1996; Revised and Accepted October 11, 1996

ABSTRACT

Recent studies have shown that many proteins are involved in the early steps of nucleotide excision repair and that there are some interactions between nucleotide excision repair proteins, suggesting that these interactions are important in the reaction mechanism. The xeroderma pigmentosum group A protein (XPA) was shown to bind to the replication protein A (RPA) or the excision repair cross complementing rodent repair deficiency group 1 protein (ERCC1), and these interactions might be involved in the damage-recognition and/or incision steps of nucleotide excision repair. Here we show that the XPA regions required for the binding to the 70 and 34 kDa subunits of RPA are located in the middle and on N-terminal regions of XPA, respectively. These regions do not overlap with the ERCC1-binding region of XPA, and a ternary protein complex of RPA, XPA and ERCC1 was detected in vitro . In addition, using the surface plasmon resonance biosensor, the binding of RPA and ERCC1 to XPA was investigated. The dissociation constants ( K D) of RPA and ERCC1 with XPA were 1.9*10-8 and 2.5*10-7 M, respectively. Moreover, our results suggest the sequential binding of RPA and ERCC1 to XPA.

INTRODUCTION

Nucleotide excision repair (NER) is the major pathway by which a broad spectrum of DNA damage, including pyrimidine dimers induced by UV, are removed from the genome. The importance of NER has been indicated by studies on an inherited human disease called xeroderma pigmentosum (XP), which is characterized by the hypersensitivity of skin to sunlight, a high incidence of sunlight-induced skin cancer, and neurological complications ( 1 , 2 ). Cells from XP patients are hypersensitive to killing by UV irradiation because of a defect in NER. There are seven different genetic complementation groups (A-G) and a variant form in XP. In addition, there are two genetic complementation groups in Cockayne syndrome (CS-A and B), which is a NER-defective hereditary disorder with clinical symptoms of neurodevelopmental delay and dwarfism, but with no increased incidence of skin cancer, and 11 complementation groups (groups 1-11) in UV-sensitive, NER-defective, rodent mutant cell lines ( 2 , 3 ). In XP and some of these mutant cells, there are defects in the early stages of NER, including the recognition of damaged DNA, generation of dual incisions on either side of the damaged region, and excision of the oligonucleotides containing the damaged site ( 4 ). In CS cells NER of total genomic DNA is normal but the increased rate of repair of the transcribed strand of active genes (transcription-coupled repair) usually seen in repair-proficient cells is absent ( 1 , 2 ). So far, XPA , XPB ( ERCC3 ), XPC , XPD ( ERCC2 ), XPF ( ERCC4, ERCC11 ), XPG ( ERCC5 ), CSA ( ERCC8 ), CSB ( ERCC6 ) and ERCC1 genes have been cloned ( 5 - 15 ). The ERCC genes are the human genes that can correct the repair deficiency in UV-sensitive rodent mutant cell lines.

In the early stages of NER, many proteins including the XP proteins are known to be involved ( 16 ). The XPA protein (XPA) preferentially binds to UV- or chemical carcinogen-damaged DNA, suggesting that XPA is involved in the damage recognition step of NER ( 17 - 19 ). XPB and XPD have helicase activity ( 20 - 23 ) and are components of the general transcription factor TFIIH ( 23 - 25 ). TFIIH was shown to participate in NER as well as in transcription. Possibly, the bi-directional helicase activities of TFIIH serve to locally unwind DNA around the damaged sites. XPG specifically nicks the DNA duplex at the 3' border of a single-stranded DNA region of a bubble structure ( 26 ) and cuts on the 3' side of the lesion ( 26 , 27 ). ERCC1 and XPF form a complex ( 10 , 28 - 31 ) which has nuclease activity ( 31 ) and cuts on the 5' side of the lesion ( 10 , 27 , 28 ). Using cell-free NER systems, RPA (replication protein A, also known as RFA and HSSB) ( 32 - 34 ), a multisubunit single-stranded DNA binding protein, was shown to be involved in NER as well as in DNA replication and recombination ( 28 , 35 - 41 ). XPC was purified as a tight complex with HHR23B (a human homologue of Saccharomyces cerevisiae Rad23) ( 42 ) which is required in the early stages of NER, although the function of the complex is not clear yet. It was shown that a factor, designated IF7, is also required for the in vitro reconstitution of the incision reaction ( 38 ).

Obviously protein-protein interactions might play important roles in NER as well as in DNA replication, recombination and transcription. Actually, the interactions between proteins related to NER have been detected in the yeast two-hybrid system and in in vitro binding experiments; XPA and ERCC1 ( 43 - 46 ), XPA and RPA ( 47 - 49 ), XPA and TFIIH ( 50 ) and XPG and RPA ( 48 ). These interactions may function to co-ordinate the early stages of NER. Here, we further analyze the interactions between XPA, RPA and ERCC1. This is the first study to provide quantitative measurements of interactions between NER proteins by biophysical techniques. The results suggest that there is a sequential order of binding of the proteins XPA, RPA and ERCC1 during assembly of the DNA repair complex. Furthermore, we present a more precise mapping than previously available of the sites of interaction between XPA and the subunits of RPA.

MATERIALS AND METHODS

Preparation of proteins

XPA with N-terminal T7.Tag (XPA) was expressed in Escherichia coli. Construction of the expression vector and purification of XPA has been described elsewhere ( 19 , 51 ). To prepare GST-XPA fusion proteins, a series of XPA cDNA fragments ( 52 ) were ligated to a pGEX vector. Escherichia coli cells transformed with each vector were grown to A 600 of 0.5, and fusion proteins were induced with 0.2 mM IPTG. After 8-10 h of additional growth at 25oC, the E.coli cells were pelleted, washed once with phosphate buffered saline (PBS), and stored at -80oC. Cells were resuspended in 1/20-1/40 culture volume of a buffer containing 50 mM Tris-HCl, pH 7.8, 500 mM NaCl, 1 mM EDTA, 1% NP-40, 1 mM DTT and 0.5 mM PMSF and lysed by sonication on ice. Lysates were centrifuged at 35 000 g for 15 min, and the cleared lysates were incubated with glutathione-Sepharose (Pharmacia Biotech) for 30 min at 4oC. The beads were washed three times with NETN (50 mM Tris-HCl, pH 7.8, 150 mM NaCl, 1 mM EDTA, 1% NP-40, 1 mM DTT and 0.5 mM PMSF). Elution of the GST fusion proteins was performed with a buffer containing 50 mM Tris-HCl, pH 8.0, 100 mM NaCl and 10 mM glutathione. The XPA and GST-XPA used in the experiments had damaged DNA binding activity ( 19 , 51 ) and were active in an in vitro repair assay (data not shown). GST-ERCC1 was induced at 37oC with 1 mM IPTG for 4 h and purified as described above. Human RPA was purified from HeLa cells ( 47 ), which was used for the BIAcore measurements. Recombinant human RPA was purified as described ( 53 ), and used in the in vitro binding assay. Recombinant p34 (the 34 kDa subunit of RPA) was partially purified from a fraction eluted with a buffer containing 0.5 M NaSCN from an Affi-Gel blue column during the purification of recombinant RPA, as described above. RPA was active, as shown by an in vitro NER assay ( 37 , 38 , 54 , 55 ). In vitro transcription and translation was performed using a TNT coupled reticulocyte lysate system (Promega) according to the manufacturer's instructions.

In vitro binding assay

GST fusion proteins (500 ng-1 [mu]g) adsorbed onto glutathione-Sepharose (10 [mu]l) were mixed with purified proteins or in vitro translation products in 1 ml of NETN containing 10 mg/ml skim milk at 4oC for 2 h and then washed five times with NETN. The bound proteins were extracted by boiling in SDS sample buffer and separated by SDS-PAGE and analyzed by immunoblotting using the ECL Western blotting detection system (Amersham) or by the BAS 2000 image analyzer (FUJIX).

BIAcore measurements

Real-time interactions of ERCC1 and RPA with XPA were monitored using the surface plasmon resonance biosensor BIAcoretm system (Pharmacia Biotech). Measurements are based on changes in surface plasmon resonance signals from chips which are covalently cross-linked with ligands ( 56 ). Changes in the signal were measured in real time, reflecting changes in the refractive index due to increased protein concentrations on the surface of the chip ( 57 ). XPA was diluted to a concentration of 1 mg/ml in HBS buffer (10 mM HEPES, pH 7.5, 150 mM NaCl, 3.4 mM EDTA and 0.05% Tween 20) and coupled to the carboxymethylated dextran-modified gold surface of a CM5 sensor chip as described in the BIAcoretm system's manual. Briefly, the carboxyl groups of the chip were activated with 50 mM N -hydroxysuccinimide and 200 mM N -ethyl- N '-(3-diethylaminopropyl)-carbodiimide for 1 min, and then the XPA solution was injected onto the activated chip for 3 min at a flow rate of 5 [mu]l/min. The remaining activated groups were blocked with 1 M ethanolamine (pH 8.5) for 6 min, and any uncoupled protein was washed with HBS buffer. Under these conditions, surfaces containing densities of 9000 resonance units (RU; an arbitrary unit for the BIAcoretm system: ~9 ng/mm 2 ) of XPA were generated. To collect sensorgrams, GST-ERCC1 and RPA were dialyzed against, and diluted with HBS buffer, and each concentration of the proteins was passed over the sensor surface at a flow rate of 10 [mu]l/min. Sensorgrams were recorded, normalized to a base line of 0 RU, and analyzed using BIA Evaluation software. The equilibrium dissociation constants ( K D ) were calculated either from the kinetic parameters or from Scatchard analysis of steady-state binding.


Figure 1 . Interaction of XPA with the subunits of RPA. In vitro translated [ 35 S]methionine-labeled p70, p34 or p11 was incubated with GST beads (lanes 2, 5 and 8) or GST-XPA beads (lanes 3, 6 and 9). After washing the beads, the bound proteins were separated by SDS-PAGE and analyzed by a FUJIX BAS 2000 image analyzer. One-tenth of each of the in vitro translation products was loaded into SDS-PAGE for input control (lanes 1, 4 or 7).

RESULTS

Bindings of p70 and p34 subunits of RPA to XPA

RPA is a heterotrimer consisting of 70, 34 and 11 kDa subunits ( 32 - 34 ) and we previously showed that XPA binds the 34 kDa subunit (p34) of RPA ( 47 ). We also examined whether the other subunits of RPA bind XPA. The GST-XPA beads were mixed with either in vitro translated p70, p34 or p11 (Fig. 1 ). p70 bound to XPA as well as p34, but p11 did not. GST-XPA used in this study was active in an in vitro repair assay.

Identification of RPA binding regions of XPA

To determine the RPA-binding regions of XPA, a series of truncated XPA proteins fused with GST were produced and used for binding to p34, p70 or RPA (Fig. 2 ). In the case of p34, the truncated XPA, which had deletions in C-terminal regions and lacked the three N-terminal amino acids, was able to bind the in vitro translated p34, while the truncated XPA, which has >29 N-terminal amino acids deleted, was unable to bind. However, truncated XPA, which has >86 C-terminal amino acids or 137 N-terminal amino acids deleted, was unable to bind the in vitro translated p70. These results indicate that amino acids 4-29 and 98-187 of XPA are required for binding to p34 and p70, respectively. When recombinant RPA, which was active in an in vitro repair assay, was bound to XPA, it showed a combination of the p34 and p70 patterns. However, deletions of the p34-binding region in XPA (N[Delta]29, N[Delta]52 and N[Delta]97) had little effect on RPA binding, whereas deletion of the p70-binding region (C[Delta]136 and N[Delta]137) caused a drastic decrease in RPA binding (Fig. 2 ). These results indicate that p70 more predominantly contributed to the XPA-binding than p34. The binding of p34 to XPA seems to be rather weak and the significance of p34 binding is unknown. However, it may costitute a binding domain in conjunction with p70.


Figure 2 . Mapping of the RPA-binding regions in XPA. In vitro binding assays were performed using GST-truncated XPA proteins as described in the Materials and Methods. ( A ) Recombinant p34; ( B ) in vitro translated [ 35 S]methionine-labeled p70; and ( C ) recombinant RPA were used for binding. The bound proteins were analyzed by immunoblotting with anti-p34 antibodies (A) or anti-p34 and p70 antibodies (C) and by the image analyzer (B). As a control, 1/100 (A) or 1/10 (B and C) of the input proteins used for binding were directly loaded into SDS-PAGE. ( D ) Schematic representation of the results.

Formation of a ternary complex of XPA, RPA and ERCC1

As the RPA-binding regions of XPA are different from the ERCC1-binding region (Fig. 6 , 44-46), it may be possible that XPA binds to both RPA and ERCC1 simultaneously. To verify the formation of a XPA-RPA-ERCC1 ternary complex in vitro , GST-ERCC1 beads were mixed with XPA (N-terminal T7.Tag XPA which was active in an in vitro repair assay) and RPA. RPA did not bind to GST-ERCC1 beads in the absence of XPA (Fig. 3 , lane 4), indicating that RPA does not bind to ERCC1 directly. But RPA bound to GST-ERCC1 beads in the presence of XPA (Fig. 3 , lane 3). These results indicate the formation of a ternary complex in vitro . Under these conditions, the interactions between XPA and RPA (Fig. 3 , lane 1) or XPA and GST-ERCC1 (Fig. 3 , lane 6) were also observed.

Binding between XPA and ERCC1 or RPA by the BIAcore system and determination of kinetic parameters

Direct interactions between ERCC1 or RPA and XPA were monitored using the BIAcore system. GST-ERCC1 and RPA solutions of various concentrations were passed over the XPA-immobilized sensor chip. Figure 4 A displays an example of overlaid sensorgrams using five different concentrations of ERCC1 (25-800 nM). The association rate constant ( k ass ) and the dissociation rate constant ( k diss ) for ERCC1 binding to the surface of XPA were 1.4 * 10 3 /M/S and 3.5 * 10 -4 /S, respectively. The equilibrium dissociation constant ( K D ), determined from the ratio of these two kinetic constants ( k diss / k ass ), was 2.5 * 10 -7 M. When RPA solutions (25-400 nM) were examined (Fig. 4 B), the binding was too fast to determine the reliability of the rate constants. The K D determined by Scatchard analysis of steady state binding levels ( R eq , relative response at equilibrium) at each concentration was 1.9 * 10 -8 M. Binding of RPA and GST-ERCC1 was not observed by the BIAcore system (data not shown).


Figure 3 . Formation of a ternary XPA-RPA-ERCC1 complex in vitro . RPA was incubated with T7.tag XPA (lanes 1, 3, 5 and 6) or without T7.tag XPA (lanes 2 and 4) on ice for 2 h, and then mixed with GST-ERCC1 beads (lanes 3, 4 and 6) or anti-XPA antibody beads (lanes 1, 2 and 5). After washing the beads, the bound proteins were separated by SDS-PAGE and analyzed by immunoblotting with anti-p34 antibodies (lanes 1-4) or anti-T7.tag antibodies (Novagen, lanes 5 and 6).


Figure 4 . Analysis of ERCC1 and RPA binding to XPA by BIAcore. Overlaid plots of sensorgrams of ERCC1 ( A ) lower to upper curve: 25, 50, 100, 200, 400 and 800 nM and RPA ( B ) lower to upper curve: 25, 50, 100, 200 and 400 nM injected over the XPA surface of the sensor chip.

Sequential binding of RPA and ERCC1 to XPA

Next we examined whether RPA and ERCC1 bound in any specific order to XPA. First, 150 nM of RPA was passed over the XPA-sensor chip. The resonance signal increased to 50 RU 300 s after the injection. Then 150 nM of ERCC1 was injected. The resonance signal increased to 206 RU, and the total resonance signal summed up to 256 RU (Fig. 5 A). These results indicate that the ternary XPA-RPA-ERCC1 complex was formed in the order of injection. Conversely, when ERCC1 was passed over the XPA-sensor chip first, the resonance signal increased to 193 RU 300 s after the injection (Fig. 5 B). The amount and binding pattern was almost identical to those obtained by ERCC1 injection in the above experiment, indicating that ERCC1 could bind to XPA irrespective of the binding of RPA to XPA. RPA was then injected onto the sensor chip which was pre-bound with ERCC1. Only a little signal increase was observed (7 RU) after the RPA injection (Fig. 5 B), indicating that the pre-binding of ERCC1 to XPA prevents the additional binding of RPA to XPA. When RPA and ERCC1 were injected simultaneously, the resonance signal increased to 268 RU, which was almost equal to that obtained by the sequential bindings of RPA and ERCC1 to XPA (Fig. 5 A and C). Injection of RPA or ERCC1 alone could not increase this score. All these results suggest that RPA bound XPA first and then ERCC1 bound to XPA.

DISCUSSION

Previously we showed that p34 bound to XPA using the yeast two-hybrid system, and the direct binding of XPA and RPA was confirmed by in vitro experiments. We have also shown that RPA was co-immunoprecipitated with XPA from whole cell lysates, indicating the existence of a complex of XPA and RPA in vivo ( 47 ). In this study, we showed that p70 bound to XPA in vitro as well as p34, which is consistent with the results of other groups ( 48 , 49 ). We confirmed that amino acids 4-29 and 98-187 of XPA were required for the binding of p34 and p70, respectively. Recently, Li et al. showed that the 58 N-terminal amino acids and amino acids 153-176 of XPA are required for p34 and p70 binding, respectively ( 49 ). The region for the binding of p70 which we determined was broader. Since Li et al. used various C-terminal truncated forms of XPA it is not excluded that other regions of XPA are required for p70 binding. Therefore, we think that these results are consistent. We recently identified a region of XPA which is responsible for its preferential binding to DNA damaged by UV or cisplatin, which consists of amino acids 98-219 (MF122) and contains a C 4 type zinc finger motif ( 51 , 58 ; Fig. 6 ). This region overlaps with the p70-binding region. It was shown that the damaged-DNA binding activity of XPA increased when XPA bound to RPA ( 48 , 49 ; our unpublished results), suggesting that the enhancement of damaged DNA-binding activity of XPA was caused by the direct binding of p70 to the DNA binding domain of XPA and that the XPA-RPA complex is involved in the damage-recognition step of NER. It was recently shown that RPA itself preferentially binds to damaged DNA ( 48 , 59 , 60 ), but complex formation between RPA and UV-damaged DNA was not affected by pre-treatment with dimer photolyase, which removes the cyclobutane pyrimidine dimers from DNA without affecting the content of the (6-4) photoproducts ( 60 ). In fact, RPA bound to substrates with bubble or loop structures ( 55 ). RPA, and probably XPA also, may recognize the single-strandedness resulting from UV lesions.


Figure 5 . Effect of the binding order of RPA and ERCC1 to XPA. ( A ) Injection of RPA (150 nM; 240 s) was followed by a 100 s wash with the binding buffer and the subsequent injection of ERCC1 (150 nM; 240 s). ( B ) The opposite order. ( C ) Simultaneous injection of RPA and ERCC1.


Figure 6 . Functional regions of XPA. NLS, nuclear localization signal; E-cluster, the glutamic acid cluster; Zn-finger, C 4 type zinc finger motif.

It was reported that ERCC1 also binds to XPA ( 43 - 46 ). We monitored the binding of RPA and ERCC1 to XPA using the BIAcore system to evaluate the modes of binding to XPA. The sensorgram patterns of these proteins (Fig. 4 ) were quite different from each other and revealed that the association and dissociation of RPA and XPA were faster than those of ERCC1, and it was estimated that the affinity for RPA to XPA was ~10-fold higher than that of ERCC1. We suggest that RPA binds to XPA first and then ERCC1 binds to XPA. ERCC1 forms a stable complex with XPF, and the complex has endonuclease activity and cuts on the 5' side of damaged sites ( 10 , 27 - 31 ). We have shown that the damaged DNA binding activity of XPA is increased by binding to ERCC1 ( 45 ). Therefore we think that ERCC1 assembled with XPA-RPA at the damaged sites and ERCC1-XPA interactions recruit the ERCC1-XPF endonuclease to damaged sites in the DNA. On the other hand, XPG is reported to bind to RPA ( 48 ), suggesting that XPA/RPA also attracts the XPG nuclease to the 3' side of damaged DNA. All these results suggest that pre-assembled XPA-RPA congregates at damaged sites and becomes the core of the incision protein complex which efficiently advances the NER reaction. It has been reported that in S.cerevisiae Rad14 binds more tightly to the Rad1-Rad10 complex than to Rad1 and Rad10 proteins alone, and a higher level of incision of UV-damaged DNA is achieved with the pre-assembled Rad1-Rad10-Rad14 complex ( 61 ). These results demonstrate that quantitative measurements of interactions between NER proteins can reveal sequential protein associations during repair, and aid in elucidating the mechanism of NER as the repair complex assembles at sites of damage in DNA.

ACKNOWLEDGEMENTS

We thank Dr M. S. Wold for human RPA expression vector (p11d-tRPA) and Dr J. Hurwitz for anti-p70 and p34 monoclonal antibodies. This work was supported by a grant-in-aid for scientific research on priority areas from the Ministry of Education, Science and Culture of Japan and Human Frontier Science Program.

REFERENCES

1 Cleaver,J.E. and Kreamer,K.H. (1995) In Scriver,C.R., Beaudet,A.L., Sly,W.S. and Valle,D. (eds), The Metabolic and Molecular Bases of Inherited Disease: Xeroderma Pigmentosum and Cockayne Syndrome. McGrow Hill, New York, 7th Ed., Vol. III, pp. 4393-4419.

2 Friedberg,E.C., Walker,G.C. and Siede,W. (1995) DNA Repair and Mutagenesis. ASM Press, Washington, DC.

3 Troelstra,C., van Gool,A., de Wit,J., Vermeulen,W., Bootsma,D. and Hoeijmakers,J.H.J. (1992) Cell, 71, 939-953. MEDLINE Abstract

4 Tanaka,K. and Wood,R.D. (1995) Trends Biochem. Sci., 19, 83-86.

5 Tanaka,K., Miura,N., Satokata,I., Miyamoto,I., Yoshida,M.C., Satoh,Y., Kondo,S.,Yasui,A., Okayama,H. and Okada,Y. (1990) Nature, 348, 73-76. MEDLINE Abstract

6 Legerski,R. and Peterson,C. (1992) Nature, 359, 70-73. MEDLINE Abstract

7 Weeda,G., van Ham,R.C.A., Vermeulen,W., Bootsma,D., van der Eb,A.J. and Hoeijmakers,J.H.J. (1990) Cell, 62, 777-791. MEDLINE Abstract

8 Weber,C.A., Salazar,E.P., Stewart,S.A. and Thompson,L.H. (1990) EMBO J., 9, 1437-1447. MEDLINE Abstract

9 Flejter,W.L., McDaniel,L.D., Jones,D., Friedberg,E.C. and Schultz,R.A. (1992) Proc. Natl. Acad. Sci. USA, 89, 261-265. MEDLINE Abstract

10 Sijbers,A.M., de Laat,W.L., Ariza,R.R., Biggerstaff,M., Wei,Y.-F., Moggs,J.G., Carter,K.C., Shell,B.K., Evans,E., de Jong,M.C., Rademakers,S., de Rooji,J., Jaspers,N.G.J., Hoeijmakers,J.H.J. and Wood,R.D. (1996) Cell, 86, 811-822. MEDLINE Abstract

11 Scherly,D., Nouspikel,T., Corlet,J., Ucla,C., Bairoch,A. and Clarkson,S.G. (1993) Nature, 363, 182-185. MEDLINE Abstract

12 O'Donovan,A. and Wood,R.D. (1993) Nature, 363, 185-188.

13 Troelstra,C., van Gool,A., de Wit,J., Vermeulen,W., Bootsma,D. and Hoeijmakers,J.H.J. (1992) Cell, 71, 939-953. MEDLINE Abstract

14 Henning,K.A., Li,L., Iyer,N., McDaniel,L.D., Reagan,M.S., Legerski,R., Schultz,R.A., Stefanini,M., Lehmann,A.R., Mayne,L.V. and Friedberg,E.C. (1995) Cell, 82, 555-564. MEDLINE Abstract

15 Itoh,T., Shiomi,T., Shiomi,N., Harada,Y., Wakasugi,M., Matsunaga,T., Nikaido,O., Friedberg,E.C. and Yamaizumi,M. (1996) Mutation Res., 362, 167-174.

16 Sancar,A. (1995) J. Biol. Chem., 270, 15915-15918. MEDLINE Abstract

17 Robins,P., Jones,C.J., Biggerstaff,M., Lindahl,T. and Wood,R.D. (1991) EMBO J., 10, 3913-3921. MEDLINE Abstract

18 Jones,C.J. and Wood,R.D. (1993) Biochemistry, 32, 12096-12104. MEDLINE Abstract

19 Asahina,H., Kuraoka,I., Shirakawa,M., Morita,E.H., Miura,N., Miyamoto,I., Ohtsuka,E., Okada,Y. and Tanaka,K. (1994) Mutation Res., 315, 229-237.

20 Sung,P., Bailly,V., Weber,C., Thompson,L.H., Prakash,L. and Prakash,S. (1993) Nature, 365, 852-855. MEDLINE Abstract

21 Roy,R., Schaeffer,L., Humbert,S., Vermeulen,W., Weeda,G. and Egly,J.-M. (1994) J. Biol. Chem., 269, 9826-9832. MEDLINE Abstract

22 Ma,L., Siemssen,E.D., Noteborn,M.H.M. and van der Eb,A.J. (1994) Nucleic Acids Res., 22, 4095-4102. MEDLINE Abstract

23 Schaeffer,L., Moncollin,V., Roy,R., Staub,A., Mezzina,M., Sarasin,A., Weeda,G., Hoeijmakers,J.H.J. and Egly,J.-M. (1994) EMBO J., 13, 2388-2392.

24 Schaeffer,L., Roy,R., Humbert,S., Moncollin,V., Vermeulen,W., Hoeijmakers,J.H.J., Chambon,P. and Egly,J.-M. (1993) Science, 260, 58-63.

25 Drapkin,R., Reardon,J.T., Ansari,A., Huang,J.-C., Zawel,L., Ahn,K., Sancar,A. and Reinberg,D. (1994) Nature, 368, 769-772. MEDLINE Abstract

26 O'Donovan,A., Davies,A.A., Moggs,J.G., West,S.D. and Wood,R.D. (1994) Nature, 371, 432-435.

27 Matsunaga,T., Mu,D., Park,C.-H., Reardon,J.T. and Sancar,A. (1995) J. Biol. Chem., 270, 20862-20869.

28 Mu,D., Hsu,D.S. and Sancar,A. (1996) J. Biol. Chem., 271, 8285-8294. MEDLINE Abstract

29 Biggerstaff,M., Szymkowski,D.E. and Wood,R.D. (1993) EMBO J., 12, 3685-3692.

30 van Vuuren,A.J., Appeldorn,E., Odijk,H., Yasui,A., Jasperse,N.G.J. and Hoeijmakers,J.H.J. (1993) EMBO J., 12, 3693-3701.

31 Park,C.-H., Bessho,T., Matsunaga,T. and Sancar,A. (1995) J. Biol. Chem., 270, 22657-22660. MEDLINE Abstract

32 Wobbe,C.R., Weissbach,L., Borowiec,J.A., Dean,F.B., Murakami,Y., Bullock,P. and Hurwitz,J. (1987) Proc. Natl. Acad. Sci. USA, 84, 1834-1838.

33 Fairman,M. P. and Stillman,B. (1988) EMBO J., 7, 1211-1218.

34 Wold,M.S. and Kelly,T. (1988) Proc. Natl. Acad. Sci. USA, 85, 2523-2527. MEDLINE Abstract

35 Coverley,D., Kenny,M.K., Munn,M., Rupp,W.D., Lane,D.P. and Wood,R.D. (1991) Nature, 349, 538-541. MEDLINE Abstract

36 Coverley,D., Kenny,M.K., Lane,D.P. and Wood,R.D. (1992) Nucleic Acids Res., 20, 3873-3880. MEDLINE Abstract

37 Mu,D., Park,C.-H., Matsunaga,T., Hsu,D.S., Reardon,J.T. and Sancar,A. (1995) J. Biol. Chem., 270, 2415-2418. MEDLINE Abstract

38 Aboussekhra,A., Biggerstaff,M., Shivji,M.K.K., Vilpo,J.A., Moncollin,V., Podust,V.N., Protic,M., Hubscher,U., Egly,J.-M. and Wood,R.D. (1995) Cell, 80, 859-868. MEDLINE Abstract

39 Guzder,S.N., Habraken,Y., Sung,P., Prakash,L. and Prakash,S. (1995) J. Biol. Chem., 270, 12973-12976.

40 Heyer,W.-D., Rao,M.R.S., Erdile,L.F., Kelly,T.J. and Kolodner,R.D. (1990) EMBO J., 9, 2321-2329. MEDLINE Abstract

41 Moore,S.P., Erdile,L., Kelly,T. and Fishel,R. (1991) Proc. Natl. Acad. Sci. USA, 88, 9067-9071. MEDLINE Abstract

42 Masutani,C., Sugasawa,K., Yanagisawa,J., Sonoyama,T., Ui,M., Enomoto,T., Takio,K., Tanaka,K., van der Spek,P.J., Bootsma,D., Hoeijmakers,J.H.J. and Hanaoka,F. (1994) EMBO J., 13, 1831-1843.

43 Park,C.-H. and Sancar,A. (1994) Proc. Natl. Acad. Sci. USA, 91, 5017-5021. MEDLINE Abstract

44 Li,L., Elledge,S.J., Peterson,C.A., Bales,E.S. and Legerski,R.J. (1994) Proc. Natl. Acad. Sci. USA, 91, 5012-5016. MEDLINE Abstract

45 Nagai,A., Saijo,M., Kuraoka,I., Matsuda,T., Kodo,N., Nakatsu,Y., Mimaki,T., Mino,M., Biggerstaff,M., Wood,R.D., Sijbers,A., Hoeijmakers,J.H.J. and Tanaka,K. (1995) Biochem. Biophys. Res. Commun., 211, 960-966. MEDLINE Abstract

46 Li,L., Peterson,C.A., Lu,X. and Legerski,R.J. (1995) Mol. Cell. Biol., 15, 1993-1998. MEDLINE Abstract

47 Matsuda,T., Saijo,M., Kuraoka,I., Kobayashi,T., Nakatsu,Y., Nagai,A., Enjoji,T., Masutani,C., Sugasawa,K., Hanaoka,F., Yasui,A. and Tanaka,K. (1995) J. Biol. Chem., 270, 4152-4157. MEDLINE Abstract

48 He,Z., Henricksen,L.A., Wold,M.S. and Ingles,C.J. (1995) Nature, 374, 566-569. MEDLINE Abstract

49 Li,L., Lu,X., Peterson,C.A. and Legerski,R.J. (1995) Mol. Cell. Biol., 41, 5396-5402.

50 Park,C.-H., Mu,D., Reardon,J.T. and Sancar,A. (1995) J. Biol. Chem., 270, 4896-4902. MEDLINE Abstract

51 Kuraoka,I., Morita,E.H., Saijo,M., Matsuda,T., Morikawa,K., Shirakawa,M. and Tanaka,K. (1996) Mutation Res., 362, 87-95.

52 Miyamoto,I., Miura,N, Niwa,H., Miyazaki,J. and Tanaka,K. (1992) J. Biol. Chem., 267, 12182-12187.

53 Henricksen,L.A., Umbrichit,C.B. and Wold,M.S. (1994) J. Biol. Chem., 269, 11121-11132. MEDLINE Abstract

54 Shivji,M.K.K., Kenny,M.K. and Wood,R.D. (1992) Cell, 69, 367-374.

55 Matsunaga,T., Park,C., Bessho,T., Mu,D. and Sancar,A. (1996) J. Biol. Chem., 271, 11047-11050. MEDLINE Abstract

56 Karlsson,R., Michaelsson,A. and Mattson,L. (1991) J. Immunol. Methods, 145, 229-240. MEDLINE Abstract

57 Fagerstam,L. (1991) Tech. Protein Chem., 2, 65-71.

58 Morita,E.H., Ohkubo,T., Kuraoka,I., Shirakawa,M., Tanaka,K. and Morikawa,K. (1996) Genes Cells, 1, 437-442.

59 Clugston,C.K., McLaughlin,K., Kenny,M.K. and Brown,R. (1992) Cancer Res., 52, 6375-6379. MEDLINE Abstract

60 Burns,J.L., Guzder,S.N., Sung,P., Prakash,S. and Prakash,L. (1996) J. Biol. Chem., 271, 11607-11610.

61 Guzder,S.N., Sung,P., Prakash,L. and Prakash,S. (1996) J. Biol. Chem., 271, 8903-8910. MEDLINE Abstract


Return

*To whom correspondence should be addressed. Tel: +81 6 879 7971; Fax: +81 6 877 9136; Email: ktanaka@imcb.osaka-u.ac.jp
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Nucleic Acids ResHome page
M. Wakasugi, H. Kasashima, Y. Fukase, M. Imura, R. Imai, S. Yamada, J. E. Cleaver, and T. Matsunaga
Physical and functional interaction between DDB and XPA in nucleotide excision repair
Nucleic Acids Res., February 1, 2009; 37(2): 516 - 525.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
K. Sugasawa
Xeroderma pigmentosum genes: functions inside and outside DNA repair
Carcinogenesis, March 1, 2008; 29(3): 455 - 465.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
E. Fanning, V. Klimovich, and A. R. Nager
A dynamic model for replication protein A (RPA) function in DNA processing pathways
Nucleic Acids Res., September 10, 2006; 34(15): 4126 - 4137.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
O. V. Tsodikov, J. H. Enzlin, O. D. Scharer, and T. Ellenberger
Crystal structure and DNA binding functions of ERCC1, a subunit of the DNA structure-specific endonuclease XPF-ERCC1
PNAS, August 9, 2005; 102(32): 11236 - 11241.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. E. Stauffer and W. J. Chazin
Structural Mechanisms of DNA Replication, Repair, and Recombination
J. Biol. Chem., July 23, 2004; 279(30): 30915 - 30918.
[Full Text] [PDF]


Home page
Nucleic Acids ResHome page
F. Guillonneau, A. L. Guieysse, S. Nocentini, C. Giovannangeli, and D. Praseuth
Psoralen interstrand cross-link repair is specifically altered by an adjacent triple-stranded structure
Nucleic Acids Res., February 13, 2004; 32(3): 1143 - 1153.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
G. W. Daughdrill, G. W. Buchko, M. V. Botuyan, C. Arrowsmith, M. S. Wold, M. A. Kennedy, and D. F. Lowry
Chemical shift changes provide evidence for overlapping single-stranded DNA- and XPA-binding sites on the 70 kDa subunit of human replication protein A
Nucleic Acids Res., July 15, 2003; 31(14): 4176 - 4183.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J.-S. You, M. Wang, and S.-H. Lee
Biochemical Analysis of the Damage Recognition Process in Nucleotide Excision Repair
J. Biol. Chem., February 21, 2003; 278(9): 7476 - 7485.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
S. J. Araújo, E. A. Nigg, and R. D. Wood
Strong Functional Interactions of TFIIH with XPC and XPG in Human DNA Nucleotide Excision Repair, without a Preassembled Repairosome
Mol. Cell. Biol., April 1, 2001; 21(7): 2281 - 2291.
[Abstract] [Full Text]


Home page
Nucleic Acids ResHome page
M. Nitta, M. Saijo, N. Kodo, T. Matsuda, Y. Nakatsu, H. Tamai, and K. Tanaka
A novel cytoplasmic GTPase XAB1 interacts with DNA repair protein XPA
Nucleic Acids Res., November 1, 2000; 28(21): 4212 - 4218.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
G. Rodrigo, S. Roumagnac, M. S. Wold, B. Salles, and P. Calsou
DNA Replication but Not Nucleotide Excision Repair Is Required for UVC-Induced Replication Protein A Phosphorylation in Mammalian Cells
Mol. Cell. Biol., April 15, 2000; 20(8): 2696 - 2705.
[Abstract] [Full Text]


Home page
Mol. Biol. CellHome page
K. W. Kohn
Molecular Interaction Map of the Mammalian Cell Cycle Control and DNA Repair Systems
Mol. Biol. Cell, August 1, 1999; 10(8): 2703 - 2734.
[Abstract] [Full Text]


Home page
Genes Dev.Home page
W. L. de Laat, N. G.J. Jaspers, and J. H.J. Hoeijmakers
Molecular mechanism of nucleotide excision repair
Genes & Dev., April 1, 1999; 13(7): 768 - 785.
[Full Text]


This Article
Right arrow Abstract Freely available
Right arrow Print PDF (218K) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (55)
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Saijo, M
Right arrow Articles by Tanaka, K
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Saijo, M
Right arrow Articles by Tanaka, K
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?